SCHEMBL5568072

SCHEMBL5568072

CCC(N)(O)c1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
AHR P35869 2/20 0.40
CHRM3 P20309 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SLC22A2 O15244 1/20 0.37
SLC22A1 O15245 1/20 0.37
PGR P06401 1/20 0.37
THRB P10828 1/20 0.37
ADRB3 P13945 1/20 0.37
OPRK1 P41145 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
KCNH2 Q12809 1/20 0.37
PDE3A Q14432 1/20 0.37
SLC47A1 Q96FL8 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13684350 0.80 SMN1; SMN2 (0.48) SMN1; SMN2L3MBTL1AHRSLC22A2SLC22A1
SCHEMBL8341741 0.80 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL18635470 0.80 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL1856676 0.80 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL23364963 0.78 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL29828412 0.78 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL30471943 0.78 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL20851528 0.78 SMN1; SMN2 (0.47) SMN1; SMN2L3MBTL1CHRM3MEN1KMT2A
SCHEMBL12717402 0.78 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1AHRCHRM3MEN1
SCHEMBL26835113 0.78 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1AHRCHRM3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546121-A4 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2007-08-15 EP disclosed
EP-1546121-A1 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-06-29 EP disclosed
WO-2004009562-A1 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2004-01-29 WO disclosed